This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


Scientists identify class of binding molecules that can be used for targeted protein degradation

Scientists identify class of binding molecules that can be used for targeted protein degradation
Graphical abstract. Credit: Cell Chemical Biology (2024). DOI: 10.1016/j.chembiol.2024.01.003

In the battle against cancer and other diseases, scientists are developing molecular weapons that can be used to stop uncontrollable cell growth.

A team of Harvard and Massachusetts General Hospital scientists have found that "cyclimids," a class of binding molecules known as ligands, offer a promising and efficient approach to removing disease-causing or malfunctioning proteins. Their distinct properties enable scientists to attack errant proteins at their molecular roots.

"For over a year we had been tackling the question of what are the natural ligands that are recognized by cereblon, a protein crucial to targeted degradation," said senior co-author Christina Woo, Morris Kahn Associate Professor of Chemistry and Chemical Biology. "This study comprehensively characterizes these ligands to provide new insights to cereblon biology and how to hijack it."

In recent years, scientists have engineered to specifically associated with disease. These molecules have two roles: they latch onto the target protein that needs to be removed, and their "warhead" engages with part of the cellular cleanup system, often binding to a protein called cereblon. Together, these specialized molecules form what scientists call a ternary complex. Once this complex is established, the target protein gets effectively marked for disposal by the cell's proteasome, which acts like a cellular recycling system.

The success of this process—removing specific proteins—is dependent on the design and efficiency of the molecular warhead, making them crucial elements in the development of therapies for various diseases, including cancer.

A molecular 'warhead' against disease
Cristina Woo (center) in her lab with study co-authors Nandini Vallavoju (from left), Wenqing Xu, Ralph Mazitschek, and Connor Payne. Credit: Kris Snibbe/Harvard Staff Photographer

In the researchers' paper published in Cell Chemical Biology, they found that minor structural changes on the cereblon ligand can dramatically alter biological activities in cells. In collaboration with the Mazitschek Lab, which has done extensive research into the identification of disease-relevant molecular targets, the researchers introduced a systematic biochemical approach for quantifying ternary complex formation. This method allows researchers to predict the cellular degradation activity of cyclimids more effectively, streamlining the development process.

"We have given the community a powerful and affordable microscope with our method," Ralph Mazitschek, co-senior author, said. "We have established a comprehensive, reliable, robust, and sensitive profiling platform that is applicable to virtually any of these small molecule degraders and molecular glue degraders."

"This was a in the truest sense of the word," said Connor Payne, postdoctoral fellow in Mazitschek's lab. "We had different expertises, and different technologies that we were developing so the synergy between them was really, really beautiful to see come to fruition."

Going forward, Woo and Mazitschek are optimistic that cyclimids and their screening platforms will be incorporated into protein-degradation strategies, which could be useful in developing drugs and treating cancers.

"I think our research will ultimately facilitate profiling many more molecules against desired targets and arrive at more selective and efficacious molecules faster," Woo said. "There are a lot of different directions this could take us."

More information: Saki Ichikawa et al, The cyclimids: Degron-inspired cereblon binders for targeted protein degradation, Cell Chemical Biology (2024). DOI: 10.1016/j.chembiol.2024.01.003

Journal information: Cell Chemical Biology

Provided by Harvard University

This story is published courtesy of the Harvard Gazette, Harvard University's official newspaper. For additional university news, visit

Citation: Scientists identify class of binding molecules that can be used for targeted protein degradation (2024, April 3) retrieved 13 April 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Scientists generate new targeted protein degradation system that tunes a cell's own proteins


Feedback to editors